Form 483

Apotex Research Private Limited Form 483, 2013-07-12

FDA issued a Form 483 to Apotex Research Private Limited on 2013-07-12 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Apotex Research Private Limited · Bengaluru, India · Issued July 12, 2013

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Jul 2013
21 CFR 211.165(e)

Test methods

Cited by Jose A Lopez Rubet, Anita Narula

12 Jul 2013
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Jose A Lopez Rubet, Anita Narula

12 Jul 2013
21 CFR 211.198(a)

Complaint Handling Procedure

Cited by Jose A Lopez Rubet, Anita Narula

Inspected site

Inspection team

JAJose A Lopez Rubet

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere